TWO SIGMA INVESTMENTS, LP - PREVAIL THERAPEUTICS INC ownership

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of PREVAIL THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$371,000
-17.9%
16,082
-63.8%
0.00%
-50.0%
Q3 2020$452,000
+30.3%
44,413
+90.9%
0.00%0.0%
Q2 2020$347,000
+39.9%
23,264
+14.5%
0.00%0.0%
Q1 2020$248,00020,3110.00%
Other shareholders
PREVAIL THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Orbimed Advisors 13,822,463$140,713,0001.77%
Omega Fund Management, LLC 187,538$1,909,0000.52%
Boxer Capital, LLC 1,123,105$11,433,0000.40%
RA Capital Management 1,915,568$19,500,0000.36%
DAFNA Capital Management LLC 75,000$764,0000.25%
QVT Financial LP 133,690$1,361,0000.17%
Woodline Partners LP 385,480$3,924,0000.13%
Virtus ETF Advisers LLC 19,773$201,0000.10%
WEXFORD CAPITAL LP 37,963$386,0000.10%
GSA CAPITAL PARTNERS LLP 53,018$540,0000.09%
View complete list of PREVAIL THERAPEUTICS INC shareholders